Fanouriakis, A. Et Al. 2018. Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. Seminars in Arthritis and Rheumatism , vol.48, no.3 , 467-474.

Fanouriakis, A., Adamichou, C., Koutsoviti, S., Panopoulos, S., Staveri, C., Klagou, A., ... Tsalapaki, C.(2018). Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. Seminars in Arthritis and Rheumatism , vol.48, no.3, 467-474.

Fanouriakis, Antonis Et Al. "Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study," Seminars in Arthritis and Rheumatism , vol.48, no.3, 467-474, 2018

Fanouriakis, Antonis Et Al. "Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study." Seminars in Arthritis and Rheumatism , vol.48, no.3, pp.467-474, 2018

Fanouriakis, A. Et Al. (2018) . "Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study." Seminars in Arthritis and Rheumatism , vol.48, no.3, pp.467-474.

@article{article, author={Antonis Fanouriakis Et Al. }, title={Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study}, journal={Seminars in Arthritis and Rheumatism}, year=2018, pages={467-474} }